Company Overview and News


Add ONVO
to your dashboard

Headline News

Garmin, Fabrinet, Salesfore.com, Hewlett Packard Enterprise and Deere & Company highlighted as Zacks Bull and Bear of the Day

10h zacks
Chicago, IL – November 20, 2017 – Zacks Equity Research highlights Garmin Ltd (GRMN - Free Report) as the Bull of the Day and Fabrinet (FN - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Salesfore.com (CRM - Free Report) , Hewlett Packard Enterprise (HPE - Free Report) and Deere & Company (DE - Free Report) . (96-1)

Zacks.com featured highlights: Michael Kors Holdings, Tyson Foods, Sprouts Farmers Market, Triple-S Management and Rayonier

10h zacks
Chicago, IL – November 20, 2017 - Stocks in this week’s article Michael Kors Holdings Limited (KORS - Free Report) , Tyson Foods, Inc. (TSN - Free Report) , Sprouts Farmers Market, Inc. (SFM - Free Report) , Triple-S Management Corporation (GTS - Free Report) and Rayonier Inc. (RYN - Free Report) (747-4)

Zacks.com featured highlights: Fortuna Silver Mines, Ritter Pharmaceuticals , Organovo Holdings, Western Digital and Willdan Group

11h zacks
Chicago, IL – November 20, 2017 - Stocks in this week’s article Fortuna Silver Mines Inc. (FSM - Free Report) , Ritter Pharmaceuticals Inc. (RTTR - Free Report) , Organovo Holdings, Inc. (ONVO - Free Report) , Western Digital Corporation (WDC - Free Report) and Willdan Group Inc. (WLDN - Free Report) (89-1)

Organovo Holdings' (ONVO) CEO Taylor Crouch on Q2 2018 Results - Earnings Call Transcript

2017-11-10 seekingalpha
Good afternoon, and welcome to the Organovo Holdings Fiscal Second Quarter 2018 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded. (46-3)

Rite Aid, Walgreens Once Again Dip into Tuesday’s 52-Week Low Club

2017-10-10 247wallst
October 10, 2017: Here are four stocks trading with heavy volume among 40 equities making new 52-week lows in Tuesday’s session. On the NYSE, advancers led decliners by about 2 to 1 and on the Nasdaq advancers led decliners by about the same ratio. (186-2)

Organovo Announces Preliminary Fiscal Second-Quarter Total Revenue; Company Restructures To Improve Operational Efficiency

2017-10-05 devicespace
SAN DIEGO, Oct. 04, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today reported preliminary unaudited total revenue for the fiscal second quarter of 2018. The Company expects to release full fiscal second-quarter financial results on November 9, 2017. The Company also announced a restructuring plan to improve operational efficiency. (61-1)

The Competitive Case For Organovo Holdings

2017-09-20 seekingalpha
3D printing is another technological milestone in the history of printing. It became a reality in the early 1980s and the biomedical industry started using it in the early 2000s. The process has gone from creating tiny sheets of tissue to entire 3D organs nowadays. 3D printers are not the very last invention though, as they were followed by Solid Ink printing and Digital printing. (46-1)

How 3-D Printing Is Changing Health Care - WSJ

2017-09-13 wsj
A year ago, an 11-year-old girl named London Secor had surgery at the Mayo Clinic to remove a rare tumor located in her pelvis. In the past, surgeons would have considered amputating one of Ms. Secor’s legs, given that the tumor had spread to the bone and nerves of her sacrum and was encroaching on her hip socket. (2-6)

Are These 3 Biotech Stocks On Your Radar Today?

2017-08-10 accesswire
CORAL GABLES, FL / ACCESSWIRE / August 10, 2017 / Overall markets continued to dip on Thursday amid increasing tensions with North Korea. This included a rise in the fear index. Traditionally speaking the markets tend to dip as back-to-school season grows near but also factoring in these additional outside, global influencers, it has been a two-day downtrend. But even in spite of these events, there are several biotech stocks that have gone against the grain this month and are seeing bullish trends on Thursday, August 10. (0-1)

Organovo Holdings Revenue Is Growing at a Snail's Pace Compared With Prior Quarters

2017-08-10 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

Organovo Holdings' (ONVO) CEO Taylor Crouch on Q1 2018 Results - Earnings Call Transcript

2017-08-10 seekingalpha
Good afternoon, and welcome to the Organovo Fiscal First Quarter 2018 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.

How Risky Is Organovo Holdings, Inc.?

2017-07-19 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

Here's Why Organovo Holdings Inc Fell 10.5% in June

2017-07-10 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

3D Printing Medical Devices Market Size is Projected to be Around $9.8 Billion by 2025 - Market Research Globe

2017-06-27 prnewswire
A research study titled, "3D Printing Medical Devices Market by Component, Technology, Application, and End User - Global Industry Analysis and Forecast to 2025" published by Crystal Market Research, states that the 3D printing medical devices market is projected to be around $9.8 billion by 2025.

Stock Research Report

Organovo Holdings, Inc. is an early commercial stage company focused on developing and commercializing functional three-dimensional (“3D”) human tissues. Using its proprietary technologies and expertise in bioprinting, Organovo Holdings is building functional 3D human tissues that mimic key aspects of native biology, and can be used in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or diseased tissues and organs. Organovo Holdings is utilizing its proprietary bioprinting platform to create human tissue constructs in 3D that mimic native human tissue composition, architecture, and function. Organovo Holdings is leveraging its unique tissue models to improve the current industry standard cell-based and animal model testing approaches, and the company believe its foundational approach provides it with the opportunity to fill many critical gaps in commercially available preclinical human tissue models as well as in tissue trans...

Click for full article
CUSIP: 68620A104